Day: June 26, 2025

TORONTO, June 26, 2025 (GLOBE NEWSWIRE) — Canadian Life Companies Split Corp. (“the Company”) is pleased to announce it has completed the overnight offering of Preferred Shares and Class A Shares of the Company. Total gross proceeds of the offering were $40.0 million, bringing the Company’s net assets to approximately $217.9 million. The shares will begin trading on the Toronto Stock Exchange under the existing symbols of LFE.PR.B (Preferred Shares) and LFE (Class A Shares). The Preferred Shares were offered at a price of $10.55 per Preferred Share to yield 6.64% and the Class A Shares were offered at a price of $6.35 per Class A Share to yield 18.90%. The offering was led by National Bank Financial Inc. The net proceeds of the offering will be used by the Company to invest in an actively managed portfolio primarily consisting...

GREENWICH, Conn., June 26, 2025 (GLOBE NEWSWIRE) — Stardust Power Inc. (NASDAQ: SDST) (the “Company”), an American developer of battery-grade lithium products, today announced that the underwriter of its previously announced public offering of common stock has exercised its option to purchase an additional 1,100,000 shares of Common Stock, resulting in additional gross proceeds of approximately $220,000. After giving effect to the exercise of the over-allotment option, the gross proceeds from the offering increased to approximately $4.52 million, before deducting underwriting fees and other estimated offering expenses payable by the Company. The exercise of the over-allotment option closed on June 25, 2025, subject to customary closing conditions. The proceeds from the over-allotment will support the completion of Stardust Power’s...

CUPERTINO, Calif., June 26, 2025 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced the pricing of its previously announced public offering with existing and new healthcare focused institutional investors for the purchase and sale of 20,000,000 shares of its common stock (or common stock equivalents in lieu thereof) together with Series C warrants to purchase up to 20,000,000 shares of common stock (the “Series C Warrants”) and Series D warrants to purchase up to 20,000,000 shares of common stock (the “Series D Warrants”), at a combined offering price of $0.50...

The Company received $4.5 million in gross proceeds at the initial closing as consideration for the issuance of a $5.0 million convertible promissory note to the institutional investor Tel Aviv, Israel, June 26, 2025 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, today announced that it has entered into a Securities Purchase Agreement (the “SPA”), with an institutional investor (the “Investor”), pursuant to which the Company may issue and sell, from time to time, convertible promissory notes (the “Promissory Notes”) in an aggregate principal amount of up to $100.0 million. Upon the signing of the SPA (the “Initial Closing”), the Company issued and sold to the Investor an initial $5.0 million Promissory Note...

WEXFORD, Pa., June 26, 2025 (GLOBE NEWSWIRE) — Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and biopharmaceutical company, is pleased to announce the filing of a registration statement on Form S-4 with the Securities and Exchange Commission (“SEC”) related to the Company’s previously announced and proposed definitive merger agreement (the “Merger”) with Z Squared Inc. (“Z Squared”). The Form S-4 includes a preliminary proxy statement/prospectus regarding the proposed transaction. The registration statement has not yet become effective, and the information contained therein is subject to change. About Coeptis Therapeutics Holdings COEPTIS, Inc., together with its subsidiaries Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc., SNAP Biosciences,...

LAS VEGAS, June 26, 2025 (GLOBE NEWSWIRE) — Jet.AI Inc. (“Jet.AI” or the “Company”) (Nasdaq: JTAI) and Consensus Core Technologies Inc. (“Consensus Core”), a provider of high-performance GPU infrastructure and AI cloud services, announced the execution of a definitive agreement to jointly develop a phased hyperscale data center campus in Midwestern Canada (the “Midwestern Project” or “Project”). The initiative positions Jet.AI as a pure-play AI data center enterprise targeting critical infrastructure shortages in the rapidly expanding artificial intelligence market. The hyperscale campus is expected to leverage Canada’s significant low-cost energy advantages to serve the growing demand for AI infrastructure. The site is located near the largest natural gas pipeline...

With reference to stock exchange notice of 14 May 2025 and partly remuneration to Mowi ASA’s shareholder-elected Board members in the form of shares. All Board members of Mowi have today purchased shares in the company as set forth below. The share purchases are pursuant to a recommendation from the Nomination Committee which was adopted by the General Assembly on 4 June 2025. The Nomination Committee is of the view that Directors on the Board of Mowi should be encouraged to invest in shares in the company, which is also in line with the Norwegian Code of Practice for Corporate Governance. Accordingly, all Board members have purchased shares at a market price of NOK 189.75 per share, equivalent to 3,186 shares in total. Following the share purchases the Board members hold the following number of shares in Mowi. Please see attached notification...

Reduction in Force Estimated to Save Over $750K or 23.4% of Annual Payroll Expenses Agreements Progress Toward Completion; Shareholder Meeting Scheduled for July 24, 2025 IRVINE, Calif., June 26, 2025 (GLOBE NEWSWIRE) — ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced strategic headcount reduction and provided an update on the merger agreement with Vyome Therapeutics and asset purchase agreement with Biorad Medisys. “While we remain confident that the GLP-1 receptor agonists like Ozempic® and Zepbound® will have a very positive long-term impact on the broader obesity treatment landscape and that our marketing campaign will stabilize and ultimately accelerate the adoption of the Lap-Band® system and Lap-Band® 2.0 FLEX, we conducted a thorough...

Collaborating on Establishing “Blockchain + Stablecoin + Smart Cold Chain” Smart Agricultural Ecosystem HONG KONG, June 26, 2025 (GLOBE NEWSWIRE) — Reitar Logtech Holdings Limited (NASDAQ: RITR) (“Reitar” or the “Company”), a pioneer in providing comprehensive “Property Logistics Technology (PLT)” solutions, today announced the signing of a strategic Memorandum of Understanding (the “MOU”) with Rich Harvest Agricultural Produce Limited (“Rich Harvest”), a leading Asian smart agriculture enterprise. With eight farming bases in China covering over 1,333 hectares (20,000 mu), the two parties intend to explore collaboration opportunities integrating blockchain traceability technology, digital payment solutions, and smart cold chain technology in cross-border agricultural supply chains to jointly build an innovative...